Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 12/04/20161 min de leitura
Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), is proposing to withdraw approval of all new animal drug applications (NADAs) providing for use of carbadox in medicated swine feed. This action is based on CVM's determination that the use of carbadox under the approved conditions of use results in residues of carcinogenic concern in the edible tissues of the treated swine.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →